Related Experiment Videos

High dose therapy for light chain amyloidosis: can we reduce treatment related mortality further?

Meletios Dimopoulos1, Efstathios Kastritis

  • 1Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece. mdimop@med.uoa.gr

Leukemia & Lymphoma
|January 19, 2008
PubMed
Abstract

No abstract available in PubMed .